Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk [Phase 3]
Phase 3 study in Japanese patients with advanced cardiovascular risk evaluated LDL-C lowering with evolocumab (AMG 145); results were posted…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2 [Phase 3]
Phase 3 trial update on reduction of LDL-C with PCSK9 inhibition in heterozygous familial hypercholesterolemia; results posted after complet…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2 [Phase 3]
Phase 3 trial update showing goal achievement after using an anti-PCSK9 antibody in statin-intolerant individuals with hyperlipidemia.
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2 [Phase 3]
Phase 3 trial update assessing LDL-C reduction with PCSK9 monoclonal antibody plus statin therapy in hyperlipidemia.
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Safety and Efficacy of a Natural Health Product in Reducing Cholesterol and Triglyceride Levels. [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating a natural health product for safety and efficacy in lowering LDL cholesterol and triglycerides has complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-12-11FDA Approved: NIACIN — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for NIACIN (nicotinic acid) as a generic product.
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care [NA]
This is a completed clinical trial update from Massachusetts General Hospital about a study aimed at improving patient safety through follow…
-
FDA approval · 2015-11-30FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for pravastatin sodium from Teva Pharmaceuticals USA, Inc., authorizing a generic pravastatin produc…
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein [Phase 1]
Phase 1 randomized trial evaluated the impact of vinegar on high-density lipoprotein (HDL) cholesterol; the study status is completed.
-
CLINICAL_TRIALS research · 2015-11-26Clinical Trial Update: Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes Patients [NA]
A completed clinical trial evaluated non-fasting versus fasting lipid measurements in diabetes patients, comparing lipid assessment methods.
-
CLINICAL_TRIALS research · 2015-11-20Clinical Trial Update: A Survey on the Under-treatment of hypercholeSterolemia (EPHESUS Trial)
ClinicalTrials.gov update on the EPHESUS Trial, surveying under-treatment of hyperlipidemia.
-
FDA approval · 2015-11-18FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Fenofibric Acid submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS research · 2015-11-18Clinical Trial Update: Treatment of Hyperlipidemia and Sexual Dysfunction [Phase 4]
This document reports a Phase 4 clinical trial evaluating treatment for hyperlipidemia and sexual dysfunction, with the current status liste…
-
FDA approval · 2015-11-17FDA Approved: AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for amlodipine besylate and atorvastatin calcium from Dr. Reddy's Laboratories Inc, enabling its mar…
-
FDA approval · 2015-11-16FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic amlodipine and atorvastatin combination from Mylan Pharmaceuticals Inc., under the AND…
-
FDA approval · 2015-11-09FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for atorvastatin calcium (generic) by Mylan Pharmaceuticals, confirming an additional aspect of its …
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: Effect Of Capros Supplementation On Cardiovascular Disease Risk Factors In Humans [NA]
A completed clinical trial evaluated Capros supplementation and its effect on cardiovascular disease risk factors in adults with hyperlipide…
-
FDA label_change · 2015-11-05FDA Approved: LESCOL XL — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for LESCOL XL (fluvastatin sodium) submitted by Sandoz Inc, resulting in labeling changes.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Effect of Rosuvastatin Therapy on HDL2 Level [Phase 4]
This clinical trial update assesses the effect of rosuvastatin therapy on HDL2 cholesterol levels in patients with hyperlipidemia and corona…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Translating a Heart Disease Lifestyle Intervention Into the Community [NA]
Northwestern University completed a trial evaluating translating a heart-disease lifestyle intervention into community settings. The study a…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Lipid-lowering Effect of a Plant Stanol Ester Supplement Product [NA]
A completed clinical trial from Raisio Group assessing the lipid-lowering effect of a plant stanol ester supplement (Benecol).
-
CLINICAL_TRIALS trial_result · 2015-10-22Clinical Trial Update: Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Evolocumab (AMG 145) in Adults With Hyperlipidemia on Stable Doses of a Statin [Phase 1]
Phase 1 ascending multiple-dose study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of evolocumab in adults with hy…
-
FDA approval · 2015-10-15FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: The Effect of a Scratch Off Prompt on Health Engagement [NA]
University of Pennsylvania-sponsored trial completed a study on whether a scratch-off prompt influences engagement with health screening for…
-
FDA approval · 2015-10-09FDA Approved: NIACIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for NIACIN (niacin), a generic product. This decision constitutes a supplementa…